| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 15959450 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 64187 journal articles in the PubMed database | Email to a friend | | |
| Llorca PM, Miadi-Fargier H, Lançon C, et al.
[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation] [Journal Article, Review]
Encephale 2005 Mar-Apr; 31(2):235-46.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | De Graeve D, Smet A, Mehnert A, et al.
Long-acting risperidone compared with oral olanzapine and haloperidol depot in schizophrenia: a Belgian cost-effectiveness analysis. [Journal Article]
Pharmacoeconomics 2005.:35-47.
Abstract | Full Citation | Find Related Articles | | Laux G, Heeg B, van Hout BA, et al.
Costs and effects of long-acting risperidone compared with oral atypical and conventional depot formulations in Germany. [Journal Article]
Pharmacoeconomics 2005.:49-61.
Abstract | Full Citation | Find Related Articles | | Yang YK, Tarn YH, Tarn YH, et al.
Pharmacoeconomic evaluation of schizophrenia in Taiwan: model comparison of long-acting risperidone versus olanzapine versus depot haloperidol based on estimated costs. [Journal Article]
Psychiatry Clin Neurosci 2005 Aug; 59(4):385-94.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Edwards NC, Rupnow MF, Pashos CL, et al.
Cost-effectiveness model of long-acting risperidone in schizophrenia in the US. [Journal Article]
Pharmacoeconomics 2005; 23(3):299-314.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Edwards NC, Locklear JC, Rupnow MF, et al.
Cost effectiveness of long-acting risperidone injection versus alternative antipsychotic agents in patients with schizophrenia in the USA. [Journal Article]
Pharmacoeconomics 2005.:75-89.
Abstract | Full Citation | Find Related Articles | | Vacheron-Trystram MN, Braitman A, Cheref S, et al.
[Antipsychotics in bipolar disorders] [Journal Article, Review]
Encephale 2004 Sep-Oct; 30(5):417-24.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Foster RH, Goa KL
Risperidone. A pharmacoeconomic review of its use in schizophrenia. [Journal Article, Review]
Pharmacoeconomics 1998 Jul; 14(1):97-133.
Abstract | Full Citation | Find Related Articles | | Chue PS, Heeg B, Buskens E, et al.
Modelling the impact of compliance on the costs and effects of long-acting risperidone in Canada. [Journal Article]
Pharmacoeconomics 2005.:62-74.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| |
Advertise on this site.
|
New! 